Cargando…

Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396574/
https://www.ncbi.nlm.nih.gov/pubmed/37538087
http://dx.doi.org/10.1155/2023/9870104
_version_ 1785083788255035392
author Markers, Disease
author_facet Markers, Disease
author_sort Markers, Disease
collection PubMed
description
format Online
Article
Text
id pubmed-10396574
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103965742023-08-03 Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer Markers, Disease Dis Markers Retraction Hindawi 2023-07-26 /pmc/articles/PMC10396574/ /pubmed/37538087 http://dx.doi.org/10.1155/2023/9870104 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Markers, Disease
Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
title Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
title_full Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
title_fullStr Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
title_full_unstemmed Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
title_short Retracted: E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
title_sort retracted: e2f1 affects the therapeutic response to neoadjuvant therapy in breast cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396574/
https://www.ncbi.nlm.nih.gov/pubmed/37538087
http://dx.doi.org/10.1155/2023/9870104
work_keys_str_mv AT markersdisease retractede2f1affectsthetherapeuticresponsetoneoadjuvanttherapyinbreastcancer